Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 03, 2020 09:30 ET | Source: Vivos Inc.

Vivos Inc Initiates IsoPet Therapy of Horses – Addressing Unmet Need for the Treatment of Equine Tumors

Richland WA, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce today that it is expanding Isopet® into the equine market by making IsoPet® available to...
October 22, 2019 07:00 ET | Source: Vivos Inc.

Vivos Inc. Reports on IsoPet® Therapy at the Veterinary Cancer Society Annual Meeting

Richland WA, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos, Inc. key personnel attended the Veterinary Cancer Society annual meeting last week in Houston Texas which was attended...
April 30, 2019 07:00 ET | Source: Vivos Inc.

Vivos Inc. Reports Progress

Richland WA, April 30, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCPINK: RDGL), provides an update on the progress towards commercialization of Y-90 IsoPet® for animal therapy. Animal...
February 25, 2019 07:00 ET | Source: Vivos Inc.

Vivos Inc. Reports on the Health of Canine Therapy Patients

Richland WA, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc. (OTCPINK: RDGL), a pharmaceutical company in the process of researching and developing minimally invasive...
February 01, 2019 16:05 ET | Source: Vivos Inc.

Vivos Inc. Issues Letter to Its Shareholders

Richland WA, Feb. 01, 2019 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL). The Board of Directors of Vivos Inc. (OTCPINK: RDGL), a pharmaceutical company in the process of researching and...
January 09, 2019 07:00 ET | Source: Vivos Inc.

Vivos Inc 2018 Highlights

Richland WA, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) The Board of Directors Reports:In spite of being handcuffed by legacy debt financing, Vivos Inc made considerable...
October 26, 2018 07:00 ET | Source: Vivos Inc.

Vivos Inc. Successfully Administers IsoPet® to a Second Dog for Canine Sarcoma at the University of Missouri

Richland WA, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc reported that the second dog in a five-dog series was successfully treated yesterday with Y-90 IsoPet® at the...
September 26, 2018 07:00 ET | Source: Vivos Inc.

First Successful Treatment of Canine Sarcoma using IsoPet® to be Presented at Veterinary Cancer Society Conference

Richland, WA, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC PINK: RDGL) first therapy to canine treat soft tissue sarcoma is successful Vivos Inc, a pharmaceutical company in the process of...
September 25, 2018 14:15 ET | Source: Vivos Inc.

Amending and Replacing the Initial Press Release on George Sharp; Disregard the first release:

Richland, WA, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Vivos Inc. (OTC: RDGL), a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in...
September 25, 2018 11:12 ET | Source: Vivos Inc.

Vivos Inc Retains Well-Known Analyst, George Sharp, as Advisor - Updated

Richland, WA, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Vivos Inc. (OTC: RDGL), a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in...